{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:44:17Z","timestamp":1793994257484,"version":"4.8.0"},"reference-count":62,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2025,1,6]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The periprocedural management of antithrombotic medications in patients with chronic subdural hematoma (cSDH) after middle meningeal artery embolization (MMAE) or surgical evacuation is uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted across Medline, Embase, and Web of Science databases. We pooled proportions and risk ratios (RRs) for the meta-analysis with the corresponding 95% CIs. Systemic and intracranial (including recurrence) bleeding complications and thromboembolic events were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 16 included studies with 4606 patients, 1784 were receiving antithrombotic medications. Antithrombotic therapy was resumed in 1231 patients (69.0%). Bleeding complications were similar between patients in whom antithrombotic therapy was resumed (14.1%, 95% CI 9.7% to 20.2%) and in those in whom it was discontinued (15.4%, 95% CI 7.4% to 29.3%). After MMAE, patients had similar rates of bleeding events (12.1%, 95% CI 4.9% to 27.0%) to patients with overall treated cSDH, and recurrence (RR 2.28, 95% CI 0.46 to 11.37) and reoperation (RR 1.07, 95% CI 0.40 to 2.917) risks were similar between the resumed and discontinued groups. Thromboembolic complications were significantly higher in the discontinued group (12.6%, 95% CI 6.5% to 23.0%) than in the resumption group (3.5%, 95% CI 1.8% to 6.9%). Earlier resumption (1\u2009week to 1\u2009month) was associated with a lower thromboembolic risk without increasing bleeding complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Post-procedural antithrombotic resumption may reduce thromboembolic events without significantly increasing bleeding risk. Early resumption of antithrombotics post-MMAE appears to be safe, although further data are required to confirm this observation. Future studies should aim to better define patient characteristics influencing decision-making in this context.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2024-022988","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T13:22:47Z","timestamp":1738156967000},"page":"468-477","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Antithrombotic resumption after middle meningeal artery embolization or surgery for chronic subdural hematoma: a systematic review and meta-analysis"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4241-2316","authenticated-orcid":false,"given":"Ahmed","family":"Alkhiri","sequence":"first","affiliation":[{"name":"King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatoon","family":"Alshaikh","sequence":"additional","affiliation":[{"name":"King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S","family":"Alqahtani","sequence":"additional","affiliation":[{"name":"Armed Forces Hospital, Southern Region, Saudi Arabia"},{"name":"Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha","family":"Alqurashi","sequence":"additional","affiliation":[{"name":"King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar M","family":"Alsharif","sequence":"additional","affiliation":[{"name":"King Abdulaziz Hospital, Makkah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad M","family":"Bukhari","sequence":"additional","affiliation":[{"name":"King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan M","family":"AlWadee","sequence":"additional","affiliation":[{"name":"Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A","family":"Alreshaid","sequence":"additional","affiliation":[{"name":"Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"},{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy","family":"Selim","sequence":"additional","affiliation":[{"name":"Stroke Division, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Alrajhi","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad S","family":"Al-Ajlan","sequence":"additional","affiliation":[{"name":"Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"},{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Alhazzani","sequence":"additional","affiliation":[{"name":"Neuroscience Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia"},{"name":"College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"2026011302200844000_18.2.468.1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.surneu.2006.07.022","article-title":"Chronic subdural hematomas--causes of morbidity and mortality","volume":"67","author":"Ramachandran","year":"2007","journal-title":"Surg Neurol"},{"key":"2026011302200844000_18.2.468.2","doi-asserted-by":"publisher","DOI":"10.1258\/jrsm.95.6.290"},{"key":"2026011302200844000_18.2.468.3","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.32.207"},{"key":"2026011302200844000_18.2.468.4","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.78.916.71"},{"key":"2026011302200844000_18.2.468.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2004.09.015"},{"key":"2026011302200844000_18.2.468.6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3340\/jkns.2008.43.1.11","article-title":"Clinical analysis of risk factors related to recurrent chronic subdural hematoma","volume":"43","author":"Ko","year":"2008","journal-title":"J Korean Neurosurg Soc"},{"key":"2026011302200844000_18.2.468.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2018.05.037"},{"key":"2026011302200844000_18.2.468.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.06.140"},{"key":"2026011302200844000_18.2.468.9","doi-asserted-by":"publisher","DOI":"10.1080\/02699050310001645801"},{"key":"2026011302200844000_18.2.468.10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1042-3680(18)30101-3","article-title":"Causes, Epidemiology, and Risk Factors of Chronic Subdural Hematoma","volume":"11","author":"Chen","year":"2000","journal-title":"Neurosurg Clin N Am"},{"key":"2026011302200844000_18.2.468.11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1591019918769336","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: Endovascular technique and radiographic findings","volume":"24","author":"Link","year":"2018","journal-title":"Interv Neuroradiol"},{"key":"2026011302200844000_18.2.468.12","first-page":"11","article-title":"Chronic Subdural Hematoma","volume":"3","author":"D\u2019Errico","year":"1930","journal-title":"Yale J Biol Med"},{"key":"2026011302200844000_18.2.468.13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/0964704X.2021.1979783","article-title":"The first historical description of chronic subdural hematoma: A tale of inaccurate interpretation, inaccurate quoting and inaccurate requoting","volume":"32","author":"Dammers","year":"2023","journal-title":"J Hist Neurosci"},{"key":"2026011302200844000_18.2.468.14","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000255"},{"key":"2026011302200844000_18.2.468.15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3340\/jkns.2018.0156","article-title":"How to Treat Chronic Subdural Hematoma? Past and Now","volume":"62","author":"Lee","year":"2019","journal-title":"J Korean Neurosurg Soc"},{"key":"2026011302200844000_18.2.468.16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4103\/ajns.AJNS_13_17","article-title":"The Role of Medical Treatment in Chronic Subdural Hematoma","volume":"13","author":"Thotakura","year":"2018","journal-title":"Asian J Neurosurg"},{"key":"2026011302200844000_18.2.468.17","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.123.044129"},{"key":"2026011302200844000_18.2.468.18","doi-asserted-by":"crossref","DOI":"10.1148\/rg.230158","article-title":"Middle Meningeal Artery Embolization for Management of Chronic Subdural Hematoma","volume":"44","author":"Schmolling","year":"2024","journal-title":"Radiographics"},{"key":"2026011302200844000_18.2.468.19","doi-asserted-by":"crossref","DOI":"10.1161\/SVIN.122.000490","article-title":"Middle Meningeal Artery Embolization to Treat Chronic Subdural Hematoma","volume":"3","author":"Rudy","year":"2023","journal-title":"SVIN"},{"key":"2026011302200844000_18.2.468.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313472"},{"key":"2026011302200844000_18.2.468.21","doi-asserted-by":"crossref","unstructured":"Fiorella D , Monteith SJ , Hanel R , et al . Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma. N Engl J Med 2024. doi:10.1056\/NEJMoa2409845","DOI":"10.1056\/NEJMoa2409845"},{"key":"2026011302200844000_18.2.468.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401201"},{"key":"2026011302200844000_18.2.468.23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jocn.2004.12.013","article-title":"Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy","volume":"13","author":"Rust","year":"2006","journal-title":"J Clin Neurosci"},{"key":"2026011302200844000_18.2.468.24","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jama.2017.0639","article-title":"Association of Antithrombotic Drug Use With Subdural Hematoma Risk","volume":"317","author":"Gaist","year":"2017","journal-title":"JAMA"},{"key":"2026011302200844000_18.2.468.25","doi-asserted-by":"crossref","first-page":"e616","DOI":"10.1016\/j.wneu.2019.12.080","article-title":"Reinitiation of Anticoagulation After Surgical Evacuation of Subdural Hematomas","volume":"135","author":"Nassiri","year":"2020","journal-title":"World Neurosurg"},{"key":"2026011302200844000_18.2.468.26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3171\/2021.3.JNS21281","article-title":"Incidence of surgery for chronic subdural hematoma in Finland during 1997-2014: a nationwide study","volume":"136","author":"Tommiska","year":"2022","journal-title":"J Neurosurg"},{"key":"2026011302200844000_18.2.468.27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jocn.2021.10.001","article-title":"Nationwide trends in middle meningeal artery embolization for treatment of chronic subdural hematoma: A population-based analysis of utilization and short-term outcomes","volume":"94","author":"Dicpinigaitis","year":"2021","journal-title":"J Clin Neurosci"},{"key":"2026011302200844000_18.2.468.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026011302200844000_18.2.468.29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.15.2008"},{"key":"2026011302200844000_18.2.468.30","doi-asserted-by":"crossref","first-page":"e792","DOI":"10.1016\/j.wneu.2017.10.091","article-title":"Resumption of Antithrombotic Agents in Chronic Subdural Hematoma: A Systematic Review and Meta-analysis","volume":"109","author":"Phan","year":"2018","journal-title":"World Neurosurg"},{"key":"2026011302200844000_18.2.468.31","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/WNL.0000000000003918","article-title":"Anticoagulant and antiplatelet use in seniors with chronic subdural hematoma: Systematic review","volume":"88","author":"Nathan","year":"2017","journal-title":"Neurology (ECronicon)"},{"key":"2026011302200844000_18.2.468.32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jocn.2016.12.001","article-title":"Influence of antithrombotic agents on the recurrence of chronic subdural hematomas and the quest about the recommencement of antithrombotic agents: A meta-analysis","volume":"38","author":"Wang","year":"2017","journal-title":"J Clin Neurosci"},{"key":"2026011302200844000_18.2.468.33","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2026011302200844000_18.2.468.34","doi-asserted-by":"publisher","DOI":"10.1097\/ede.0000000000001232"},{"key":"2026011302200844000_18.2.468.35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clineuro.2016.10.002","article-title":"Optimal perioperative management of antithrombotic agents in patients with chronic subdural hematoma","volume":"151","author":"Amano","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"key":"2026011302200844000_18.2.468.36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jocn.2020.01.076","article-title":"Impact of antithrombotic therapy on surgical treatment in patients with chronic subdural hematoma","volume":"74","author":"Amano","year":"2020","journal-title":"J Clin Neurosci"},{"key":"2026011302200844000_18.2.468.37","first-page":"31","article-title":"Subdural Hematoma and Oral Anticoagulation: A Therapeutic Dilemma from the Neurosurgical Point of View","volume":"77","author":"Mirzayan","year":"2016","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"key":"2026011302200844000_18.2.468.38","doi-asserted-by":"crossref","first-page":"106318","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106318","article-title":"Safety of Antithrombotic Resumption in Chronic Subdural Hematoma Patients with Middle Meningeal Artery Embolization: A Case Control Study","volume":"31","author":"Mir","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026011302200844000_18.2.468.39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/02688690120097822","article-title":"Warfarin and chronic subdural haematomas","volume":"15","author":"Gonugunta","year":"2001","journal-title":"Br J Neurosurg"},{"key":"2026011302200844000_18.2.468.40","doi-asserted-by":"publisher","DOI":"10.3171\/2015.2.JNS141889"},{"key":"2026011302200844000_18.2.468.41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1227\/NEU.0000000000001393","article-title":"Does Early Resumption of Low-Dose Aspirin After Evacuation of Chronic Subdural Hematoma With Burr-Hole Drainage Lead to Higher Recurrence Rates?","volume":"79","author":"Kamenova","year":"2016","journal-title":"Neurosurgery"},{"key":"2026011302200844000_18.2.468.42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7887\/jcns.22.625","article-title":"Resumption of Antithrombotic Therapy and the Operative Procedure in Recurrent Chronic Subdural Hematoma","volume":"22","author":"Tsushima","year":"2013","journal-title":"Jpn J Neurosurg"},{"key":"2026011302200844000_18.2.468.43","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2011.2074"},{"key":"2026011302200844000_18.2.468.44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuchi.2020.04.136","article-title":"Impact of discontinuation of antithrombotic therapy after surgery for chronic subdural hematoma","volume":"66","author":"Todeschi","year":"2020","journal-title":"Neurochirurgie"},{"key":"2026011302200844000_18.2.468.45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jocn.2021.05.036","article-title":"Impact of time to resumption of antithrombotic therapy on outcomes after surgical evacuation of chronic subdural hematoma: A multicenter cohort study","volume":"89","author":"Zhang","year":"2021","journal-title":"J Clin Neurosci"},{"key":"2026011302200844000_18.2.468.46","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00701-022-05337-0","article-title":"The effect of antithrombotic therapy on the recurrence and outcome of chronic subdural hematoma after burr-hole craniostomy in a population-based cohort","volume":"164","author":"Kerttula","year":"2022","journal-title":"Acta Neurochir (Wien)"},{"key":"2026011302200844000_18.2.468.47","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1227\/neu.0000000000002452","article-title":"Outcome of Chronic Subdural Hematoma Intervention in Patients on Long-Term Antiplatelet Therapy-A Propensity Score Matched Analysis","volume":"93","author":"Salih","year":"2023","journal-title":"Neurosurgery"},{"key":"2026011302200844000_18.2.468.48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1227\/neu.0000000000002222","article-title":"Middle Meningeal Artery Embolization for Chronic Subdural Hematomas With Concurrent Antithrombotics","volume":"92","author":"Martinez-Gutierrez","year":"2023","journal-title":"Neurosurgery"},{"key":"2026011302200844000_18.2.468.49","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00701-017-3330-x","article-title":"Role of antithrombotic therapy in the risk of hematoma recurrence and thromboembolism after chronic subdural hematoma evacuation: a population-based consecutive cohort study","volume":"159","author":"Fornebo","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"key":"2026011302200844000_18.2.468.50","doi-asserted-by":"crossref","unstructured":"Chaliparambil RK , Krushelnytskyy M , Nandoliya KR , et al . Safety of Postembolization Antithrombotic Therapy After Middle Meningeal Artery Embolization. Neurosurgery 2024. doi:10.1227\/neu.0000000000003176","DOI":"10.1227\/neu.0000000000003176"},{"key":"2026011302200844000_18.2.468.51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/02688697.2013.812184","article-title":"Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis","volume":"28","author":"Chari","year":"2014","journal-title":"Br J Neurosurg"},{"key":"2026011302200844000_18.2.468.52","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1016\/j.wneu.2019.08.175","article-title":"Time to and Possible Risk Factors for Recurrence after Burr-hole Drainage of Chronic Subdural Hematoma: A Subanalysis of the cSDH-Drain Randomized Controlled Trial","volume":"132","author":"Lutz","year":"2019","journal-title":"World Neurosurg"},{"key":"2026011302200844000_18.2.468.53","doi-asserted-by":"crossref","unstructured":"D\u00e9sir LL , D\u2019Amico R , Link T , et al . Middle Meningeal Artery Embolization and the Treatment of a Chronic Subdural Hematoma. Cureus 2021;13. doi:10.7759\/cureus.18868","DOI":"10.7759\/cureus.18868"},{"key":"2026011302200844000_18.2.468.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.04.063"},{"key":"2026011302200844000_18.2.468.55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jcin.2021.01.040","article-title":"Antithrombotic Management of Elderly Patients With Coronary Artery Disease","volume":"14","author":"Capranzano","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2026011302200844000_18.2.468.56","doi-asserted-by":"crossref","unstructured":"Brannigan JFM , Gillespie CS , Adegboyega G , et al . Impact of antithrombotic agents on outcomes in patients requiring surgery for chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg 2024;1\u20138. doi:10.1080\/02688697.2024.2333399","DOI":"10.1080\/02688697.2024.2333399"},{"key":"2026011302200844000_18.2.468.57","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-126-2-199701150-00006"},{"key":"2026011302200844000_18.2.468.58","unstructured":"Amaraneni A , Chippa V , Goldin J , et al . Anticoagulation safety. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2024."},{"key":"2026011302200844000_18.2.468.59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1607181","article-title":"Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis","volume":"2019","author":"Paciaroni","year":"2019","journal-title":"Cardiovasc Ther"},{"key":"2026011302200844000_18.2.468.60","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062770"},{"key":"2026011302200844000_18.2.468.61","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010582","article-title":"Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?","volume":"7","author":"Edmiston","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026011302200844000_18.2.468.62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03975.x"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2024-022988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T10:22:11Z","timestamp":1768299731000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2024-022988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":62,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1,13]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/jnis-2024-022988"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2024-022988","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}